Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cartesi (CTSI) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

Cartesi vs Enzyme — how do they compare? Cartesi trades at Rp443.09 (market cap Rp413,7M, Rp51,93M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Cartesi is far larger — about 3.1× Enzyme's market cap, and Cartesi's supply is capped (932,9M / 1B CTSI (94%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cartesi for 91 Days and Enzyme for 29 Days on average.

CTSIMLN
Market Cap
Rp413,7MRp134,13M
Volume (24h)
Rp51,93MRp104,56M
Circulating Supply
932,9M / 1B CTSI (94%)3,3M MLN
Typical Hold Time
91 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cartesi

Cartesi (CTSI) shows bullish technical momentum with current price at Rp450.01, trading near the pivot point of Rp448. The asset maintains strong market cap of Rp418.98M with 94% circulating supply. Technical indicators show bullish moving averages and strong trend strength (ADX 82.48), though oscillators remain neutral. Support levels hold at Rp439-Rp426, with resistance at Rp461-Rp483.

Overall outlook remains cautiously optimistic with strong technical momentum but limited recent ecosystem developments. Key opportunity lies in potential breakout above Rp461 resistance, while risks include typical crypto volatility and lack of major protocol updates. Investors should monitor volume patterns and network activity closely.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CTSI
0% Buy100% Sell
Avg holding period · 91 Days
MLN

No sentiment data available yet.

About Cartesi

Cartesi (CTSI) is the first OS on the blockchain. It bridges the gap between mainstream software and blockchain, welcoming millions of new startups and their developers to blockchain by bringing Linux to blockchain applications. Cartesi combines a groundbreaking virtual machine, optimistic roll-ups, and side-chains to revolutionize the way developers create blockchain applications.

Read more on CTSI

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN